Rational approaches to anthelmintic discovery include the design of sc
reens for compounds directed at specific proteins in helminths that ar
e pharmacologically distinguishable from their vertebrate homologues.
The existence of several anthelmintics that selectively target the neu
romusculature of helminths (e.g. levamisole, ivermectin, praziquantel,
metrifonate), together with recent basic research in helminth physiol
ogy, have contributed to the recognition that neurobiology distinguish
es these organisms from their vertebrate hosts. In this survey, we foc
us on mechanism-based screening and its application to anthelmintic di
scovery, with particular emphasis on targets in the neuromusculature o
f helminths. Few of these proteins have been exploited in chemotherapy
. However, recent studies in comparative pharmacology and molecular bi
ology, including the C. elegans genome project, have provided insights
on potential new targets and, in some cases, molecular probes useful
for their incorporation in mechanism-based screens.